BIOMARKERS TO PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY IN CANCER
Author(s):
Kriti Jain, Shyam Aggarwal, Surajit Ganguly, Nirmal Kumar Ganguly, Amit Awasthi, Deepa Mehra
Keywords:
Immune checkpoint inhibitors, PD1/PD-L1, CTLA4, biomarkers, immunotherapy, solid tumors, predictive biomarkers
Abstract
Traditional treatment modalities for advanced cancer act directly on tumors to inhibit growth or destroy them. Along with surgery, these modalities are predominantly palliative, though associated with toxicity and modest improvements in survival of patients with advanced solid tumors. To address these issues, novel immunotherapies targeting programmed death-1 (PD-1/PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA4) have been developed and approved by the FDA. These therapies have been proven to provide substantial benefit and success in advanced solid tumors of different types. However, these expensive checkpoint inhibitor therapies extend clinical benefits to only a small subset of patients. Hence, it is crucial to comprehend the determinants and the role of biomarkers that drive response, resistance, and adverse effects. In this review, we have elaborated on the role of various biomarkers both pre-treatment and post-treatment which assist in predicting response to immune checkpoint inhibitors in cancer treatment.
Article Details
Unique Paper ID: 156858

Publication Volume & Issue: Volume 9, Issue 5

Page(s): 205 - 221
Article Preview & Download


Share This Article

Conference Alert

NCSST-2021

AICTE Sponsored National Conference on Smart Systems and Technologies

Last Date: 25th November 2021

SWEC- Management

LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT

Last Date: 7th November 2021

Go To Issue



Call For Paper

Volume 8 Issue 4

Last Date 25 September 2021

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews

Contact Details

Telephone:6351679790
Email: editor@ijirt.org
Website: ijirt.org

Policies